25-31 July 200900
 
 
 
 
 
 
 
 
 
 
India Emerging As Key Player
in Global Pharma Expansion
The pharmaceutical industry is one example of a truly worldwide market, with many of the largest players extending their operations to the four corners of the globe in a bid to improve their products and boost market share. In this global...
 
Big Pharma in for Rough Ride as
Recession Reduces Profits
Big Pharma initially coped better than other sectors with recession but has begun to underperform. But bleak prospects of more competition, problems of getting new drugs to market and cheaper medicines are looming on investors' radars.
 
FMCG Giant Dabur Enters Healthcare
Via Buyout Route
Fast moving consumer goods (FMCG) company Dabur is planning to acquire more companies in the healthcare segment in India and could pay out up to Rs 500 crore for the buyouts. The move follows the recent acquisition of Fem Care Pharma for over Rs 250 crore.
 
Advent International on Verge of Ozone's
Portfolio Takeover
Advent International, a buyout firm based in US that holds local drug maker LaborMed, is on the verge of taking over Ozone's product array, without sharing any financial details of the deal.
A senior official of Advent International...
 
Gujarat's 36 Pharma Brands Among
India's Top 300 Drugs
Of the 300 top medicine brands with the highest sales in India, 36 are owned and marketed by Gujarat-based companies. This remarkable fact is revealed by a list of the country's top-selling medicine brands, included in an ORG-IMS report.
 
F&B Focus '09 Offers Insight into
Bio-tech Applications
The Frost & Sullivan's Food & Beverage Focus 2009, an annual executive 'mindXchange' on biotechnology applications in the food & beverage and nutritional supplements sector summit, was organized by Frost & Sullivan's on 24 July 2009 in Mumbai.
 
Dr. Reddy's Cure for Meltdown:
Exploit More, Explore Less
Scientists have discovered a genetic clue that could prevent the growth and development of colorectal cancer. The Singapore team found that when the gene called RUNX3 is disrupted, colorectal cancer can occur. RUNX3 suppresses abnormal cell growth.
 
Firm Baring India to Tap SME Pharma
Space to Fund Growth
Baring Private Equity Partners India intends to finance the inorganic growth opportunities in the small-medium enterprises (SMEs) of the pharma sector. SMEs are showing considerable promise in highly potential areas like clinical trials and contract...
 
CONTACT
enquiry@newmediacomm.biz
New Media Communication Pvt Ltd,
New Media House, 1 Akbar Villa, Near Old State Bank, Marol-Maroshi Road,
Andheri (East), Mumbai 400 059. (INDIA) Tel: +91-22-2925 3086/ 2920 8888
     
  Satya Swaroop: Managing Editor
Dev Varam: Group Editor
Prajwala Poojary: Senior Executive- Special Projects
Sagar Banawalikar: Visualiser
 
Disclaimer: Since India has no anti-spamming law, we follow the US directive
passed in Bill 1618. Title III by 105th US Congress, which states that mail cannot
considered spam if it contains contact information, which this mail does. This mail is not a Spam Mail. In case you donot wish to receive mails then kindly click on the unsubscribe link.
In future if you want to subscribe kindly send a mail to prajwala@newmediacomm.biz
 
Readers can contribute Articles, Reports, Case Studies, Success Stories, Advertorials besides formal Advertisements.